Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2020-12-30 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
第四届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司 (Pulike Bioengineering Co., Ltd.). It details the date and manner of the meeting, attendance, and specific agenda items approved by the board, including related party transactions and a project investment. There is no financial data, no mention of annual or quarterly reports, no voting results from shareholder meetings, and no indication of regulatory filings or legal proceedings. The content fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management.
2020-12-30 Chinese
关于全资子公司获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about its wholly-owned subsidiary obtaining a new veterinary drug registration certificate. It details the drug's information, development background, market context, and regulatory procedures still required before market launch. The document is short (1322 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is not a report publication announcement since it does not mention the release of a report but rather announces a regulatory milestone. The content fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about a new product approval by a government authority (Agriculture and Rural Affairs Ministry).
2020-12-29 Chinese
关于全资子公司获得兽药产品批准文号的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding its wholly-owned subsidiary obtaining veterinary drug product approval numbers. It details product names, approval numbers, validity periods, regulatory compliance, and the impact on the company. There is no financial data, no mention of financial results, no management discussion, no shareholder voting, no legal proceedings, or other report types. The document is an official announcement about regulatory approval of products, which fits best under Regulatory Filings (RNS) as it is a regulatory announcement that does not fit other specific categories.
2020-12-16 Chinese
关于参股公司通过生物安全三级防护检查验收并获得《兽药生产许可证》《兽药GMP证书》的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 普莱柯生物工程股份有限公司 regarding its associate company 中普生物制药有限公司 obtaining the Veterinary Drug Production License and Veterinary Drug GMP Certificate after passing biosecurity and GMP inspections. It details certificate numbers, validity periods, production lines, and market impact. The document is a regulatory announcement about certifications and approvals, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. The document length is short (1940 characters) and it is an announcement of a regulatory milestone. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-12-09 Chinese
关于股东减持超过1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a shareholder's reduction in shareholding by more than 1%. It details the shareholder's name, the number of shares reduced, the percentage change, and confirms that the reduction does not affect control of the company. It is a typical announcement of a major shareholding change. The document length is short (1680 characters), and it is not a full financial report or earnings release. It fits the definition of a Major Shareholding Notification (MRQ).
2020-12-07 Chinese
关于股东减持股份时间过半暨数量过半的进展公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the progress of a major shareholder's planned reduction of shares through centralized bidding. It includes details about the shareholder's holdings, the amount and timing of shares sold, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial analysis, nor is it a report or presentation. It is a regulatory announcement about a major shareholding change, specifically a progress update on a share reduction plan by a significant shareholder. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is under 5,000 characters and is a direct announcement, not a report publication or certification. Hence, the classification is MRQ with high confidence.
2020-12-07 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.